Joyce Russell
Known title: DirectorCIK: 0001890294
Associated companies
Transaction History
| CELH | ▼ Sell | Open Market | 2,880 | $148K | 3/2/2026 | View on chart |
| CELH | ▲ Buy | Grant | 2,611 | $0 | 2/27/2026 | View on chart |
| CELH | ▼ Sell | Open Market | 4,000 | $114K | 3/11/2025 | View on chart |
| CELH | ▲ Buy | Grant | 4,865 | $0 | 3/1/2025 | View on chart |
| CELH | ▲ Buy | Grant | 1,576 | $0 | 3/1/2024 | View on chart |
| CELH | ▼ Sell | Open Market | 500 | $86K | 8/11/2023 | View on chart |
| CELH | ▲ Buy | Grant | 1,105 | — | 1/1/2023 | View on chart |
| CELH | ▲ Buy | Grant | 2,200 | — | 1/1/2022 | View on chart |
| CELH | ▲ Buy | Grant | 2,750 | — | 10/28/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Celsius Holdings sees analyst coverage and turnaround focus
Recent coverage of Celsius includes a lowered price target to $35 from TD Cowen while the consensus analyst target stays near $42. Analysts note a possible recovery but limited upside, pointing to recent acquisitions and the Alani Nu brand as part of a turnaround plan. A separate note mentions Boston Beer’s upcoming earnings, which could influence the broader beverage sector in which Celsius operates.
Celsius Holdings sees analyst coverage and turnaround focus. Recent coverage of Celsius includes a lowered price target to $35 from TD Cowen while the consensus analyst target stays near $42. Analysts note a possible recovery but limited upside, pointing to recent acquisitions and the Alani Nu brand as part of a turnaround plan. A separate note mentions Boston Beer’s upcoming earnings, which could influence the broader beverage sector in which Celsius operates.